Outcome of respiratory failure in hematologic malignancy

Area of Science:

• Pulmonology
• Oncology
• Critical Care Medicine

Background:

• Patients with hematologic malignancy often require mechanical ventilation (MV) due to respiratory complications.
• Respiratory failure in this population is associated with significant morbidity and mortality.

Purpose of the Study:

• To evaluate the outcomes of hematologic malignancy patients requiring mechanical ventilation.
• To identify prognostic factors and diagnostic yield of invasive procedures in this patient cohort.

Main Methods:

• Retrospective review of 119 episodes of mechanical ventilation in 116 patients with hematologic malignancy between 1976 and 1985.
• Analysis of in-hospital mortality, survival duration, and factors influencing outcomes.
• Review of diagnostic procedures including bronchoscopy and open lung biopsy (OLB).

Main Results:

• Overall in-hospital mortality was 82%.
• Of the 18% who survived, the median survival was 12 months.
• Survival rates varied by hematologic malignancy type: chronic lymphocytic leukemia (42%), other leukemias (16%), Hodgkin's disease (29%), and non-Hodgkin's lymphomas (6%).
• Bronchoscopy and OLB provided diagnoses in a majority of cases but were associated with low survival rates, especially OLB (2/23 survivors).

Conclusions:

• Respiratory failure in patients with hematologic malignancy requiring mechanical ventilation carries a very high mortality.
• While diagnostic procedures can identify causes of respiratory failure, they do not significantly improve survival.
• Individualized patient care is crucial, considering the poor prognosis for long-term recovery in this group.